Dorothee Uriet

Dorothee Uriet is an experienced professional with a strong background in clinical affairs and regulatory management, currently serving as Clinical and Development Practice Director at RebrAIn since October 2024 and participating in the Innovation Management and Entrepreneurship Executive Program at HEC Paris since June 2024. Previously, Uriet held key positions at BrainTale as Chief Regulatory and Clinical Affairs Officer and Clinical Affairs Director from October 2019 to March 2024, with responsibilities including clinical affairs management as a member of the Executive Committee. Prior roles include Clinical Operations Manager and CMO deputy at Theraclion and International Clinical Project Manager at Keyrus Life Science, contributing expertise in oncology, rheumatology, and clinical evaluations across various therapeutic areas. Uriet's educational credentials include degrees in therapeutic strategies, innovation management, biochemistry, biostatistics, and biotechnology from notable institutions including UFR pharmacie Reims, HEC Paris, and Pierre and Marie Curie University.